ASH Stock - Ashland Inc.
Unlock GoAI Insights for ASH
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $1.82B | $2.11B | $2.19B | $2.39B | $2.11B |
| Gross Profit | $549.00M | $618.00M | $668.00M | $830.00M | $670.00M |
| Gross Margin | 30.1% | 29.2% | 30.5% | 34.7% | 31.7% |
| Operating Income | $-775,000,000 | $-26,000,000 | $172.00M | $333.00M | $192.00M |
| Net Income | $-845,000,000 | $169.00M | $178.00M | $927.00M | $220.00M |
| Net Margin | -46.3% | 8.0% | 8.1% | 38.8% | 10.4% |
| EPS | $-17.87 | $3.45 | $3.36 | $17.17 | $2.85 |
Ashland Inc. provides additives and specialty ingredients worldwide. It operates through Life Sciences; Personal Care & Household; Specialty Additives; and Intermediates and Solvents segments. The Life Sciences segment offers pharmaceutical solutions, including controlled release polymers, disintegrants, tablet coatings, thickeners, solubilizers, and tablet binders; nutrition solutions, such as thickeners, stabilizers, emulsifiers, and additives; and nutraceutical solutions comprising products for weight management, joint comfort, stomach and intestinal health, sports nutrition, and general wellness, as well as custom formulation, toll processing, and particle engineering solutions. The Personal Care & Household segment provides a range of nature-based, biodegradable, and performance ingredients; solutions for toothpastes, mouth washes and rinses, denture cleaning, and care for teeth; and household supplies nature-derived rheology ingredients, biodegradable surface wetting agents, performance encapsulates, and specialty polymers. The Specialty Additives segment offers rheology modifiers, foam control agents, surfactants and wetting agents, pH neutralizers, advanced ceramics used in catalytic converters, environmental filters, ingredients for the manufacturing of ceramic capacitors, plasma display panels and solar cells, ingredients for textile printing, thermoplastic metals, and alloys for welding. The Intermediates and Solvents segment produces 1,4 butanediol and related derivatives, including n-methylpyrrolidone. It offers its products to customers in a range of consumer and industrial markets, such as architectural coatings, construction, energy, food and beverage, nutraceuticals, personal care, and pharmaceutical. The company was formerly known as Ashland Global Holdings Inc. Ashland Inc. was founded in 1924 and is based in Wilmington, Delaware.
Visit WebsiteRating Distribution
Price Targets
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| December 15th 2025 | BMO Capital Markets | Upgrade | Outperform | $71 |
| September 8th 2025 | Morgan Stanley | Initiation | Equal Weight | $60 |
| May 1st 2025 | Wells Fargo | Downgrade | Equal Weight | - |
| March 26th 2025 | JP Morgan | Upgrade | Overweight | $71← $68 |
| March 5th 2025 | Seaport Research Partners | Downgrade | Neutral | - |
| August 8th 2024 | JP Morgan | Upgrade | Neutral | $89← $90 |
| April 11th 2024 | Wells Fargo | Upgrade | Overweight | $112← $100 |
| March 14th 2024 | Jefferies | Upgrade | Buy | $126← $100 |
| March 1st 2024 | Wolfe Research | Initiation | Outperform | $108 |
| June 29th 2023 | Evercore ISI | Downgrade | In-line | - |
| June 26th 2023 | BMO Capital Markets | Downgrade | Market Perform | $90← $109 |
| February 2nd 2023 | JP Morgan | Downgrade | Underweight | $105← $104 |
| September 12th 2022 | Credit Suisse | Initiation | Outperform | $120 |
Earnings History & Surprises
ASHEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | Apr 28, 2026 | — | — | — | — |
Q1 2026 | Jan 27, 2026 | $0.24 | — | — | — |
Q4 2025 | Nov 4, 2025 | $1.17 | $1.08 | -7.7% | ✗ MISS |
Q3 2025 | Jul 29, 2025 | $1.15 | $1.04 | -9.6% | ✗ MISS |
Q2 2025 | Apr 30, 2025 | $1.10 | $0.99 | -10.0% | ✗ MISS |
Q1 2025 | Jan 28, 2025 | $0.79 | $0.28 | -64.6% | ✗ MISS |
Q4 2024 | Nov 7, 2024 | $1.28 | $1.26 | -1.6% | ✗ MISS |
Q3 2024 | Aug 6, 2024 | $1.47 | $1.49 | +1.4% | ✓ BEAT |
Q2 2024 | Apr 30, 2024 | $1.14 | $1.27 | +11.4% | ✓ BEAT |
Q1 2024 | Jan 30, 2024 | $0.19 | $0.45 | +136.8% | ✓ BEAT |
Q4 2023 | Nov 8, 2023 | $0.47 | $0.41 | -12.8% | ✗ MISS |
Q3 2023 | Jul 25, 2023 | $1.27 | $1.23 | -3.1% | ✗ MISS |
Q2 2023 | May 2, 2023 | $1.50 | $1.43 | -4.7% | ✗ MISS |
Q1 2023 | Jan 31, 2023 | $0.95 | $0.97 | +2.1% | ✓ BEAT |
Q4 2022 | Nov 7, 2022 | $1.39 | $1.46 | +5.0% | ✓ BEAT |
Q3 2022 | Jul 26, 2022 | $1.88 | $1.89 | +0.5% | ✓ BEAT |
Q2 2022 | Apr 26, 2022 | $1.36 | $1.50 | +10.3% | ✓ BEAT |
Q1 2022 | Feb 1, 2022 | $0.87 | $0.88 | +1.1% | ✓ BEAT |
Q4 2021 | Nov 9, 2021 | $1.28 | $1.22 | -4.7% | ✗ MISS |
Q3 2021 | Jul 27, 2021 | $1.29 | $1.22 | -5.4% | ✗ MISS |
Latest News
Wells Fargo Maintains Equal-Weight on Ashland, Raises Price Target to $60
📈 PositiveMizuho Maintains Outperform on Ashland, Raises Price Target to $70
📈 PositiveBMO Capital Upgrades Ashland to Outperform, Raises Price Target to $71
📈 PositiveAshland gains as Standard Investments discloses stake of 5.7%
📈 PositiveMizuho Maintains Outperform on Ashland, Raises Price Target to $60
📈 PositiveWells Fargo Maintains Equal-Weight on Ashland, Lowers Price Target to $51
➖ NeutralEvercore ISI Group Maintains In-Line on Ashland, Lowers Price Target to $53
➖ NeutralAshland Sees FY2026 Sales $1.835B-$1.905B vs $1.826B Est
📈 PositiveAshland Q4 Adj. EPS $1.08 Misses $1.24 Estimate, Sales $478.000M Miss $480.553M Estimate
📉 NegativeWells Fargo Maintains Equal-Weight on Ashland, Lowers Price Target to $52
📉 NegativeMizuho Maintains Outperform on Ashland, Lowers Price Target to $54
➖ NeutralAshland Production Unit At Calvert City Is Offline, Equipment Requires Replacement With No Impact Expected To Customer Orders; Repairs Expected To Complete In Fiscal Q1 2026; Expects No Impact On Customer Deliveries Or Sales Commitments During Outage Period
➖ NeutralMorgan Stanley Initiates Coverage On Ashland with Equal-Weight Rating, Announces Price Target of $60
➖ NeutralBMO Capital Maintains Market Perform on Ashland, Raises Price Target to $61
➖ NeutralArgus Research Maintains Buy on Ashland, Lowers Price Target to $65
📈 PositiveFrequently Asked Questions about ASH
What is ASH's current stock price?
What is the analyst price target for ASH?
What sector is Ashland Inc. in?
What is ASH's market cap?
Does ASH pay dividends?
Similar Stocks
Basic Materials SectorExplore stocks similar to ASH for comparison